TSR INC (TSRI) Fundamental Analysis & Valuation

NASDAQ:TSRI • US8728852075

Current stock price

13.38 USD
+0.01 (+0.04%)
At close:
13.3584 USD
-0.02 (-0.16%)
After Hours:

This TSRI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. TSRI Profitability Analysis

1.1 Basic Checks

  • In the past year TSRI was profitable.
  • In the past year TSRI had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: TSRI reported negative net income in multiple years.
  • The reported operating cash flow has been mixed in the past 5 years: TSRI reported negative operating cash flow in multiple years.
TSRI Yearly Net Income VS EBIT VS OCF VS FCFTSRI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M 6M

1.2 Ratios

  • With a decent Return On Assets value of 7.75%, TSRI is doing good in the industry, outperforming 76.83% of the companies in the same industry.
  • The Return On Equity of TSRI (10.80%) is better than 71.95% of its industry peers.
  • TSRI has a Return On Invested Capital of 7.89%. This is in the better half of the industry: TSRI outperforms 68.29% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for TSRI is significantly below the industry average of 10.44%.
  • The last Return On Invested Capital (7.89%) for TSRI is above the 3 year average (5.05%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.75%
ROE 10.8%
ROIC 7.89%
ROA(3y)10.96%
ROA(5y)3.33%
ROE(3y)15.7%
ROE(5y)1.83%
ROIC(3y)5.05%
ROIC(5y)N/A
TSRI Yearly ROA, ROE, ROICTSRI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40

1.3 Margins

  • The Profit Margin of TSRI (2.15%) is comparable to the rest of the industry.
  • In the last couple of years the Profit Margin of TSRI has grown nicely.
  • TSRI has a Operating Margin (2.34%) which is comparable to the rest of the industry.
  • TSRI's Operating Margin has improved in the last couple of years.
  • The Gross Margin of TSRI (17.57%) is worse than 92.68% of its industry peers.
  • TSRI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.34%
PM (TTM) 2.15%
GM 17.57%
OM growth 3YN/A
OM growth 5Y13.97%
PM growth 3YN/A
PM growth 5Y16.86%
GM growth 3Y3.5%
GM growth 5Y1.53%
TSRI Yearly Profit, Operating, Gross MarginsTSRI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 5 10 15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. TSRI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TSRI is destroying value.
  • Compared to 1 year ago, TSRI has less shares outstanding
  • There is no outstanding debt for TSRI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
TSRI Yearly Shares OutstandingTSRI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M 2M
TSRI Yearly Total Debt VS Total AssetsTSRI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

2.2 Solvency

  • An Altman-Z score of 8.47 indicates that TSRI is not in any danger for bankruptcy at the moment.
  • TSRI has a better Altman-Z score (8.47) than 90.24% of its industry peers.
  • There is no outstanding debt for TSRI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.47
ROIC/WACC0.77
WACC10.19%
TSRI Yearly LT Debt VS Equity VS FCFTSRI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 5M 10M 15M

2.3 Liquidity

  • A Current Ratio of 3.37 indicates that TSRI has no problem at all paying its short term obligations.
  • TSRI has a better Current ratio (3.37) than 81.71% of its industry peers.
  • TSRI has a Quick Ratio of 3.37. This indicates that TSRI is financially healthy and has no problem in meeting its short term obligations.
  • TSRI's Quick ratio of 3.37 is amongst the best of the industry. TSRI outperforms 81.71% of its industry peers.
Industry RankSector Rank
Current Ratio 3.37
Quick Ratio 3.37
TSRI Yearly Current Assets VS Current LiabilitesTSRI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. TSRI Growth Analysis

3.1 Past

  • TSRI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.48%, which is quite impressive.
  • TSRI shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 24.57% yearly.
  • The Revenue for TSRI has decreased by -13.51% in the past year. This is quite bad
  • Measured over the past years, TSRI shows a quite strong growth in Revenue. The Revenue has been growing by 9.30% on average per year.
EPS 1Y (TTM)20.48%
EPS 3YN/A
EPS 5Y24.57%
EPS Q2Q%377.5%
Revenue 1Y (TTM)-13.51%
Revenue growth 3Y19.72%
Revenue growth 5Y9.3%
Sales Q2Q%-18.78%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TSRI Yearly Revenue VS EstimatesTSRI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

Find the best growth stocksShow best growing peers

4

4. TSRI Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 15.56 indicates a correct valuation of TSRI.
  • TSRI's Price/Earnings ratio is a bit cheaper when compared to the industry. TSRI is cheaper than 75.61% of the companies in the same industry.
  • TSRI's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.42.
Industry RankSector Rank
PE 15.56
Fwd PE N/A
TSRI Price Earnings VS Forward Price EarningsTSRI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of TSRI indicates a rather cheap valuation: TSRI is cheaper than 84.15% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, TSRI is valued cheaply inside the industry as 84.15% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 13.32
EV/EBITDA 7.99
TSRI Per share dataTSRI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.63
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. TSRI Dividend Analysis

5.1 Amount

  • TSRI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

TSRI Fundamentals: All Metrics, Ratios and Statistics

TSR INC

NASDAQ:TSRI (6/28/2024, 8:00:01 PM)

After market: 13.3584 -0.02 (-0.16%)

13.38

+0.01 (+0.04%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)04-10
Earnings (Next)08-09
Inst Owners6.6%
Inst Owner Change-43.85%
Ins Owners38.36%
Ins Owner Change0%
Market Cap29.03M
Revenue(TTM)88.82M
Net Income(TTM)1.91M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 15.56
Fwd PE N/A
P/S 0.33
P/FCF 13.32
P/OCF 13.32
P/B 1.64
P/tB 1.85
EV/EBITDA 7.99
EPS(TTM)0.86
EY6.43%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1
FCFY7.51%
OCF(TTM)1
OCFY7.51%
SpS40.93
BVpS8.15
TBVpS7.23
PEG (NY)N/A
PEG (5Y)0.63
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA 7.75%
ROE 10.8%
ROCE 11.4%
ROIC 7.89%
ROICexc 19.04%
ROICexgc 25.92%
OM 2.34%
PM (TTM) 2.15%
GM 17.57%
FCFM 2.46%
ROA(3y)10.96%
ROA(5y)3.33%
ROE(3y)15.7%
ROE(5y)1.83%
ROIC(3y)5.05%
ROIC(5y)N/A
ROICexc(3y)9.78%
ROICexc(5y)N/A
ROICexgc(3y)13.54%
ROICexgc(5y)N/A
ROCE(3y)7.31%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y1.93%
ROICexc growth 3YN/A
ROICexc growth 5Y-3.61%
OM growth 3YN/A
OM growth 5Y13.97%
PM growth 3YN/A
PM growth 5Y16.86%
GM growth 3Y3.5%
GM growth 5Y1.53%
F-Score8
Asset Turnover3.6
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage 250
Cash Conversion 95.05%
Profit Quality 114.1%
Current Ratio 3.37
Quick Ratio 3.37
Altman-Z 8.47
F-Score8
WACC10.19%
ROIC/WACC0.77
Cap/Depr(3y)40.97%
Cap/Depr(5y)64.58%
Cap/Sales(3y)0.1%
Cap/Sales(5y)0.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.48%
EPS 3YN/A
EPS 5Y24.57%
EPS Q2Q%377.5%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-13.51%
Revenue growth 3Y19.72%
Revenue growth 5Y9.3%
Sales Q2Q%-18.78%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-11.3%
EBIT growth 3YN/A
EBIT growth 5Y24.57%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y217.24%
FCF growth 3YN/A
FCF growth 5Y9.41%
OCF growth 1Y229.8%
OCF growth 3YN/A
OCF growth 5Y9.14%

TSR INC / TSRI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for TSR INC?

ChartMill assigns a fundamental rating of 5 / 10 to TSRI.


What is the valuation status for TSRI stock?

ChartMill assigns a valuation rating of 4 / 10 to TSR INC (TSRI). This can be considered as Fairly Valued.


How profitable is TSR INC (TSRI) stock?

TSR INC (TSRI) has a profitability rating of 5 / 10.


Can you provide the financial health for TSRI stock?

The financial health rating of TSR INC (TSRI) is 9 / 10.